
European Journal of Medicinal Chemistry p. 217 - 226 (1990)
Update date:2022-08-04
Topics:
Brown
Armitage
Blakemore
Blurton
Durant
Ganellin
Ife
Parsons
Rawlings
Slingsby
A series of 2-[2-(5-dimethylaminomethyl-2-furanylmethylthio)ethylamino]-4-pyrimidones is described containing a variety of substituents in the 5-position of the pyrimidone (isocytosine) ring. Good H2-receptor histamine antagonist activity is retained over a range of basic and neutral, polar and non-polar substituents and the majority of compounds are selective for the H2-receptor. Modifications have also been made to the furan ring and N,N-dimethylaminomethyl substituent and structure-activity observations are discussed. Compound (16f) 2-[2-(5-dimethylaminomethyl-2-furanylmethylthio)ethylamino]-5-(6-methyl-3- pyridylmethyl)-4-pyrimidone (SK and F 93479, lupitidine), a compound which shows an extended duration of anti-secretory activity in animal models, was selected for clinical investigation.
View MoreContact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
YingYing Pharmaceutical Co.,Ltd
Contact:86-18854126208
Address:55#, yingxiongshan road
Chongqing Rong&Quan Pharmaceutical Technology Co. , Ltd.
Contact:86-023-65268721
Address:No. 7, Manshanhong Village, Pingdingshan, Shapingba District, Chongqing Province, China
Shandong united-rising pharmaceutical cooperation.,ltd.
Contact:008653187965009
Address:171No., Jing5 Road, Shizhong District, Jinan, China
Contact:+86-571-86217390
Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Doi:10.1246/bcsj.39.1201
(1966)Doi:10.1002/hlca.19800630125
(1980)Doi:10.1080/00397919308013297
(1993)Doi:10.1021/jo00379a018
(1987)Doi:10.1007/BF02665113
(1956)Doi:10.1039/P19910000781
(1991)